Madrigal Pharmaceuticals Inc (MDGL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -52,546 | -202,244 | -143,121 | -85,158 | -36,135 |
| Depreciation Amortization | 113 | 471 | 355 | 240 | 125 |
| Accounts payable and accrued liabilities | 3,379 | -161 | 5,099 | 3,826 | -63 |
| Other Working Capital | 2,908 | 23,482 | 24,556 | 19,619 | 658 |
| Other Operating Activity | 2,717 | 20,891 | 10,497 | 6,709 | 4,909 |
| Operating Cash Flow | $-43,429 | $-157,561 | $-102,614 | $-54,764 | $-30,506 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -33,420 | 160,114 | 164,902 | 70,146 | 50,774 |
| PPE Investments | -44 | -334 | -324 | -321 | -314 |
| Investing Cash Flow | $-33,464 | $159,780 | $164,578 | $69,825 | $50,460 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 478 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 66,616 | 5,088 | 459 | 109 | N/A |
| Financing Cash Flow | $67,094 | $5,088 | $459 | $109 | $N/A |
| Beginning Cash Position | 54,004 | 46,697 | 46,697 | 46,697 | 46,697 |
| End Cash Position | 44,205 | 54,004 | 109,120 | 61,867 | 66,651 |
| Net Cash Flow | $-9,799 | $7,307 | $62,423 | $15,170 | $19,954 |
| Free Cash Flow | |||||
| Operating Cash Flow | -43,429 | -157,561 | -102,614 | -54,764 | -30,506 |
| Capital Expenditure | -44 | -334 | -324 | -321 | -314 |
| Free Cash Flow | -43,473 | -157,895 | -102,938 | -55,085 | -30,820 |